Key statistics
As of last trade, Turnstone Biologics Corp (TSBX:NMQ) traded at 0.67, 15.52% above the 52 week low of 0.58 set on Sep 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.687 |
---|---|
High | 0.701 |
Low | 0.6496 |
Bid | 0.6534 |
Offer | 0.678 |
Previous close | 0.6745 |
Average volume | 116.55k |
---|---|
Shares outstanding | 23.13m |
Free float | 22.24m |
P/E (TTM) | -- |
Market cap | 15.60m USD |
EPS (TTM) | -3.49 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 17:57 BST.
More ▼
- Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
- Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
- Turnstone Biologics Appoints William Waddill to its Board of Directors
- Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
- Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
More ▼